COGNITION THERAPEUTICS, INC.

Analyst Reco. Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq Other stock markets 01:30:00 27/06/2024 am IST			5-day change	1st Jan Change
1.7 ^USD	-3.41%		-15.42%	-8.11%

07/06	Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target	MT
29/05	HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target	07/06	MT
HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target	29/05	MT
Ladenburg Thalmann Cuts Cognition Therapeutics' Price Target to $6 From $10, Keeps Buy Rating	14/23/14	MT
B. Riley Cuts Cognition Therapeutics' PT to $5 From $15, Notes Near-Term Dilution, Expanding R&D Efforts to Execute on Phase II/III Programs; Keeps Buy Rating	06/23/06	MT
Oppenheimer Adjusts Cognition Therapeutics Price Target to $9 From $18, Maintains Outperform Rating	15/22/15	MT
Cantor Fitzgerald Starts Cognition Therapeutics at Overweight With $12 Price Target	29/22/29	MT
Ladenburg Thalmann Starts Cognition Therapeutics at Buy With $10 Price Target	22/22/22	MT
B. Riley Lowers Cognition Therapeutics' PT to $15 from $20, Keeps Buy Rating	01/22/01	MT
Oppenheimer Adjusts Cognition Therapeutics' Price Target to $18 From $22, Maintains Outperform Rating	31/22/31	MT
B. Riley Lowers Cognition Therapeutics' Price Target to $20 from $27 After Revising Cost Capital Assumptions, Keeps Buy Rating	24/22/24	MT
Oppenheimer Starts Cognition Therapeutics at Outperform with $22 PT On Potential Offered By Lead Dementia Drug Candidate CT1812	03/21/03	MT
B. Riley Starts Cognition Therapeutics at Buy with $27 PT, Notes Conviction in Proprietary, Mid-Stage Pipeline	03/21/03	MT
Oppenheimer Starts Cognition Therapeutics at Outperform with $22 Price Target	03/21/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer